Study readiness·August 17, 2026·7 min read

Pending QC vs Worklist Smart Routing

Routing sorts a queue of studies. Pending QC decides whether a study belongs in that queue. The worklist object routing runs on has no state that means "the record is not ready."

Pending QC and worklist smart routing act on different objects. Pending QC evaluates the study record — order agreement, laterality, reason for exam, priors, open holds — and decides whether a study is eligible to be interpreted at all. Smart routing evaluates a queue of already-eligible studies and decides which one a radiologist opens next. That split is structural, not stylistic: in the DICOM worklist model routing runs on, a work item's state is SCHEDULED, IN PROGRESS, COMPLETED, or CANCELED, and none of those values means the record underneath is unfinished. Reordering a queue redistributes a fixed amount of reading capacity. It cannot make an incomplete study complete.

The worklist has no state for "not ready"

Start with the data model routing operates on. DICOM's Unified Procedure Step service is the standard's worklist object: one item holds both the step that was scheduled and the record of the step as performed. Its Procedure Step State attribute takes exactly four values — SCHEDULED, IN PROGRESS, COMPLETED, CANCELED. There is no held, blocked, or waiting-on-a-prior value, and no route back: setting an item's state to SCHEDULED fails from every other state, so a step that turns out to have been premature is canceled and the remaining work has to be scheduled as a different item.

Real worklists layer their own columns on that, and some of them model a hold. The point is what the routing layer is native to. Its vocabulary is scheduling and progress: when a step is due, who claimed it, whether it finished. Readiness is a different kind of statement — that the order, modality, body part, and laterality agree with what was performed, that the reason for exam will support this case type, that referenced priors arrived, that holds and open remediation are closed. What makes a study read-ready walks that list, and the access it takes to satisfy it — tags, statuses, source corrections — is why PACS admins own the last mile rather than the reading roster.

A routing engine sorts studies. It holds no opinion about whether the record under a study is finished, because the object it sorts does not carry one.

10:12, and distribution is not what failed

A lumbar MRI finishes at 10:12. Images are in PACS. The order reads L-spine without contrast. The reason for exam is blank. The tech note references a prior from an outside facility that never arrived. The study sits in Pending.

At 10:40 someone asks whether the worklist needs smarter auto-assignment. The study never reached distribution, so distribution is not the thing that failed. Handing it to the next available reader does not produce a reason for exam, retrieve the prior, or fill the field that both the report and the claim will need. It relocates an unfinished record one step closer to a radiologist.

What reordering actually buys

Routing is unusually well measured, because AI triage products are routing under study. The most useful result is not the headline minutes but which interval they came out of.

26.3 vs 26.5 min
mean radiologist read time after vs before AI worklist reprioritization — statistically unchanged, while the turnaround gain came entirely out of wait timeBatra et al., AJR (2023), single center, 2,501 CTPA examinations

In that study, PE-positive exams went from a mean 59.9-minute report turnaround to 47.6 minutes, and the wait interval — exam completion to report initiation — went from 33.4 to 21.4 minutes. Read time did not move. The tool reprioritized 12.7% of exams in the post-implementation period, and during regular operational hours the wait-time improvement showed up for routine-priority exams (15.3 vs 43.7 minutes) but not for stat or urgent ones, which were already near the front. One center, one retrospective comparison, one finding type, so treat the magnitudes as local. The mechanism generalizes: reordering changed when a study got attention, not the work involved in it.

A 2025 preprint from FDA and University of Chicago authors asks when that mechanism has anything to work with. At their site, CTPA turnaround fell from a mean 68.9 to 46.7 minutes during weekday work hours, but only 44.8 to 42.0 minutes off-hours, which was not significant. Their queueing model reproduced both, and adding a fourth radiologist to the work-hours shift drove the predicted benefit toward zero. Preprint, one site, but the direction is intuitive: reordering pays where studies are genuinely queued behind each other and pays nothing where capacity absorbs arrivals as they land. That is a real thing to buy. It is also the whole of what routing does, and none of it touches a study that should not have entered the queue.

"Deprioritize the incomplete ones" is a tail-latency plan

The usual compromise is to feed incompleteness into the ranking instead of gating on it. Incomplete studies stay in the pool and sort lower. Ranking has a known failure mode when the signal misses.

A Hamburg group simulated their chest radiograph workflow over roughly 11,000 simulated days, comparing first-in-first-out reading against AI urgency ranking. Averages dropped hard — pneumothorax 80.1 to 35.6 minutes — while worst cases went the other way: maximum turnaround rose from 890 to 1,178 minutes for pneumothorax and from 916 to 2,018 minutes for congestion, because studies the model scored negative sorted to the back of the list. Retuning for a low false-negative rate made the pneumothorax worst case worse, not better. What helped was a rule from outside the ranking: promote anything that has waited past a threshold.

Different question, simulated, single site. The transferable shape is that a ranking signal's misses do not disappear, they become tail latency. Apply it to readiness and the arithmetic is worse than in the imaging case, because a deprioritized incomplete study is not merely late — it is unfixed. No one was assigned the missing prior. It ages until a reader opens it and stalls, or until it surfaces as an aging exception at the point where someone has to explain the turnaround number. A gate produces the artifact ranking cannot: a named next step attached to a named person, with the study held out of the reading path until that step closes.

Two intervals, two owners

Practices that run both well keep the sequence explicit, with a handoff that has a state on each side:

  1. Pending QC clears the study as read-ready, or holds it with issue context and an owner.
  2. Only read-ready studies enter the assignment pool.
  3. Routing, acuity tiers, sub-specialty pools, and load balancing operate on that pool.
  4. Final reader assignment stays a reading-workflow decision, downstream of the QC record.

Measure the two intervals separately: exam complete to read-ready, then read-ready to report initiation. A blended turnaround number averages a missing prior together with a busy MSK reader and tells you neither. Splitting them is also how you find out which lever your money should buy, which is the point the turnaround time work eventually forces.

One pass through last week's aging studies, sorted by cause rather than by reader, usually settles it:

  • Stuck on completeness, classification, priors, or paperwork → readiness gap.
  • Complete and correctly described, still waiting on a reader pool → routing or staffing gap, and the evidence above says routing helps most when this bucket is deep.
  • Complete but opened and returned by readers → your readiness criteria are softer than the reading desk's.

Where Corena fits

Corena works studies in a PACS Pending queue as operational QC before reading. Checks run against versioned site and case policy; a check it cannot evaluate stays unknown rather than quietly passing; findings carry the evidence behind them; and a proposed correction or handoff waits for a human to approve it before anything is written back to a source system. The internal sequence is deliberately unforgiving about what counts as done: a recommendation is not an approval, an approval is not a source write, a write response is not a verified read-back, and a verified action is not a Pending exit. Assignment sits past the end of all of that.

So the buying question is not which product has smarter queues. It is which object the product acts on: the record, or the order of the queue. If a demo opens on auto-assignment and never shows a blocked study with an owner and a next step, you are looking at routing. Request a demo to see what the gate does instead.

Frequently asked questions

Is Pending QC the same as smart worklist routing?
No. Pending QC evaluates the study record and decides whether the study is eligible to be read. Smart routing evaluates a queue of eligible studies and decides which one gets opened next. The DICOM worklist item routing runs on carries scheduling states — scheduled, in progress, completed, canceled — and no state meaning the record is unfinished.
Can routing rules replace a readiness gate?
Not reliably. Deprioritizing incomplete studies leaves them in the reading path with no owner, so they age instead of getting fixed. Simulation work on AI worklist ranking shows the same pattern in the imaging case: studies the ranking signal misses move to the tail of the queue rather than out of it, and worst-case turnaround gets longer even as averages improve.
Does improving TAT always mean buying a routing product?
Only where your delay sits in assignment and capacity among studies that are already ready. Published results are consistent about the mechanism: reprioritization compresses the wait interval, not read time, and the measured benefit shrinks toward nothing when readers are keeping up with arrivals. If studies age on missing priors, blank reasons for exam, laterality conflicts, or open holds, no ordering of that queue helps.
Where does radiologist assignment sit relative to Corena?
Outside the product boundary. Corena's scope ends at operational QC and a safe ready-for-reading handoff, and clearing a study out of Pending is not the same event as assigning it to a reader. Final reader assignment stays a downstream reading-workflow decision.
How should ops evaluate a "smarter queue" pitch?
Ask which object it acts on. A readiness tool changes whether a study becomes readable at all and can hold one back with an owner attached; a routing tool changes the order in which readable studies get opened. Both can be worth buying, but they are different purchases, and a demo that only ever shows a reordered queue is answering the second question.

Sources

  1. Radiologist Worklist Reprioritization Using Artificial Intelligence: Impact on Report Turnaround Times for CTPA Examinations Positive for Acute Pulmonary Embolism (Batra et al., AJR, 2023)
  2. Smart chest X-ray worklist prioritization using artificial intelligence: a clinical workflow simulation (Baltruschat et al., European Radiology, 2021)
  3. Impact of AI-Triage on Radiologist Report Turnaround Time: Real-World Time-Savings and Insights from Model Predictions (Thompson et al., preprint, 2025)
  4. DICOM PS3.4 Annex CC: Unified Procedure Step Service and SOP Classes (Procedure Step State transitions)

Keep reading

See Corena check a study for read-readiness — before it reaches the radiologist.

Corena flags what is missing and routes exceptions to a named human. Clean studies keep moving; they do not wait on a click.